Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.

Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, indicating a site UI/version maintenance change rather than an update to the trial record itself.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the history log.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history page.SummaryDifference0.1%

- Check83 days agoChange DetectedA new Revision: v3.4.2 has been added to the record history, replacing the previous v3.4.1. This is a minor UI/versioning update that does not affect clinical trial data or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check90 days agoChange DetectedA minor revision update from v3.4.0 to v3.4.1 is shown in the history; there are no changes to study data, status, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.